Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients

BACKGROUND: A new approach to the treatment of COPD includes controlling inflammation because of its important role in exacerbation of the disease. Recently, roflumilast has been added as a therapeutic option for COPD. Roflumilast is an oral phosphodiesterase-4 inhibitor that targets inflammatory ce...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Chron Obstruct Pulmon Dis
Main Authors: Porpodis, Konstantinos, Domvri, Kalliopi, Zarogoulidis, Paul, Petridis, Dimitrios, Tsirgogianni, Katerina, Papaioannou, Antonis, Hatzizisi, Olga, Kioumis, Ioannis, Liaka, Alexandra, Kikidaki, Violeta, Lampaki, Sofia, Organtzis, John, Zarogoulidis, Konstantinos
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2015
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474389/
https://ncbi.nlm.nih.gov/pubmed/26109853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S83205
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker